We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-1.75%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$742M
AUM Growth
+$71.9M
Cap. Flow
+$95.5M
Cap. Flow %
12.87%
Top 10 Hldgs %
60.42%
Holding
166
New
21
Increased
99
Reduced
7
Closed
7
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCP
26
DELISTED
TC Pipelines LP
TCP
$6.46M 0.87%
123,526
+22,910
+23% +$1.23M
ENLC
27
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$6.29M 0.85%
364,345
+67,678
+23% +$1.17M
WES icon
28
Western Midstream Partners
WES
$19.8B
$5.76M 0.78%
139,927
+26,030
+23% +$1.07M
TRGP icon
29
Targa Resources
TRGP
$61.3B
$4.29M 0.58%
90,638
+15,270
+20% +$694K
VPU
30
Vanguard Utilities ETF
VPU
$8.83B
$3.42M 0.46%
29,270
+6,127
+26% +$724K
FTEC icon
31
Fidelity MSCI Information Technology Index ETF
FTEC
$20.1B
$2.93M 0.39%
63,417
-8,038
-11% -$361K
VDE icon
32
Vanguard Energy ETF
VDE
$10.1B
$1.72M 0.23%
18,349
+5,653
+45% +$502K
WELL.PRI
33
DELISTED
Welltower Inc.
WELL.PRI
$1.64M 0.22%
25,828
+5,334
+26% +$348K
ENTA icon
34
Enanta Pharmaceuticals
ENTA
$377M
$1.51M 0.2%
32,235
ENB icon
35
Enbridge
ENB
$123B
$1.46M 0.2%
34,816
+6,454
+23% +$262K
NBIX icon
36
Neurocrine Biosciences
NBIX
$17.5B
$1.44M 0.19%
23,551
ACOR
37
DELISTED
Acorda Therapeutics
ACOR
$1.42M 0.19%
500
SRPT icon
38
Sarepta Therapeutics
SRPT
$1.68B
$1.42M 0.19%
31,233
TVTX icon
39
Travere Therapeutics
TVTX
$5.27B
$1.41M 0.19%
56,653
HALO icon
40
Halozyme
HALO
$9.59B
$1.36M 0.18%
78,354
NKTR icon
41
Nektar Therapeutics
NKTR
$2.34B
$1.35M 0.18%
3,742
CLVS
42
DELISTED
Clovis Oncology, Inc.
CLVS
$1.35M 0.18%
16,349
VNDA icon
43
Vanda Pharmaceuticals
VNDA
$322M
$1.34M 0.18%
74,733
GILD icon
44
Gilead Sciences
GILD
$162B
$1.29M 0.17%
15,926
BIIB icon
45
Biogen
BIIB
$29.6B
$1.28M 0.17%
4,085
EXEL icon
46
Exelixis
EXEL
$14B
$1.27M 0.17%
52,621
VRTX icon
47
Vertex Pharmaceuticals
VRTX
$120B
$1.26M 0.17%
8,300
CQP icon
48
Cheniere Energy
CQP
$31.9B
$1.25M 0.17%
43,552
+8,118
+23% +$235K
FNCL icon
49
Fidelity MSCI Financials Index ETF
FNCL
$2.33B
$1.25M 0.17%
33,040
-38,232
-54% -$1.4M
CELG
50
DELISTED
Celgene Corp
CELG
$1.25M 0.17%
8,551

Similar funds

Virtus ETF Advisers's Q3 2017 Portfolio in Review

As of Q3 2017, Virtus ETF Advisers held 166 positions worth $742M, up 11% from $670M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Virtus ETF Advisers deployed $95.5M of net new capital in Q3 2017, opening 21 new positions and adding to 99 existing holdings. Its largest new stake was Direxion Daily Financial Bull 3x ETF: 20,503 shares worth $1.15M.

By sector, the portfolio is most concentrated in Energy at 74% of assets, down from 74% a quarter earlier, followed by Healthcare.

On the sell side, the largest reduction was Plains All American Pipeline, an estimated $1.69M trimmed.

  • Virtus ETF Advisers's largest Q3 2017 buy was Direxion Daily Financial Bull 3x ETF: 20,503 shares worth $1.15M.
  • Virtus ETF Advisers added most to Marathon Petroleum in Q3 2017, an estimated $23M increase.
  • Virtus ETF Advisers's biggest Q3 2017 reduction was Plains All American Pipeline, cutting an estimated $1.69M.
  • Virtus ETF Advisers fully exited Oneok Partners LP in Q3 2017, selling an estimated $34.2M.
  • Virtus ETF Advisers's ten largest holdings make up 60% of its $742M portfolio in Q3 2017.
  • Virtus ETF Advisers opened 21 new positions and closed 7 in Q3 2017.
  • Virtus ETF Advisers's portfolio value rose 11% quarter-over-quarter to $742M.

Based on Virtus ETF Advisers's 13F filing for Q3 2017, filed 14 Nov 2017.